Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
183,255,226
-
Number of holders
-
192
-
Total 13F shares, excl. options
-
117,646,567
-
Shares change
-
+8,957,894
-
Total reported value, excl. options
-
$1,073,655,355
-
Value change
-
+$78,398,633
-
Put/Call ratio
-
80%
-
Number of buys
-
87
-
Number of sells
-
-79
-
Price
-
$9.13
Significant Holders of HERON THERAPEUTICS, INC. /DE/ - Common Stock, par value $0.01 per share (HRTX) as of Q4 2021
232 filings reported holding HRTX - HERON THERAPEUTICS, INC. /DE/ - Common Stock, par value $0.01 per share as of Q4 2021.
HERON THERAPEUTICS, INC. /DE/ - Common Stock, par value $0.01 per share (HRTX) has 192 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 117,646,567 shares
of 183,255,226 outstanding shares and own 64.2% of the company stock.
Largest 10 shareholders include FRANKLIN RESOURCES INC (11,967,465 shares), VANGUARD GROUP INC (9,609,045 shares), UBS OCONNOR LLC (8,275,000 shares), BAKER BROS. ADVISORS LP (8,131,678 shares), TANG CAPITAL MANAGEMENT LLC (7,782,928 shares), STATE STREET CORP (7,692,411 shares), BlackRock Inc. (7,682,201 shares), ArrowMark Colorado Holdings LLC (6,405,865 shares), JPMORGAN CHASE & CO (6,254,739 shares), and PFM Health Sciences, LP (3,512,348 shares).
This table shows the top 192 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.